Heart Failure
What is Heart Failure?
Heart failure is a chronic condition where the heart is unable to pump blood effectively to meet the body's needs. This can lead to a buildup of fluid in the lungs, legs, and other tissues, causing congestion and swelling.
Causes and Risk Factors
- Coronary artery disease: The most common cause, involving the narrowing or blockage of coronary arteries.
- High blood pressure: Forces the heart to work harder, which can weaken it over time.
- Heart attack: Damages the heart muscle, affecting its pumping ability.
- Cardiomyopathy: Disease of the heart muscle from genetic conditions, infections, or alcohol abuse.
- Diabetes: Increases the risk of developing heart failure.
Symptoms of Heart Failure
Common symptoms include:
- Shortness of breath, especially during exertion or when lying down
- Fatigue and weakness
- Swelling in the legs, ankles, and feet
- Rapid or irregular heartbeat
- Persistent cough or wheezing with white or pink-tinged mucus
- Increased need to urinate at night
- Sudden weight gain from fluid retention
Diagnosis and Treatment
Diagnostic Tests
To diagnose heart failure, doctors may use:
- Physical examination: To check for signs of fluid retention and listen to the heart.
- Blood tests: To check for markers indicating heart failure.
- Imaging tests: Such as echocardiograms, X-rays, and MRI to assess heart function.
- Electrocardiogram (ECG): To detect irregular heart rhythms.
Treatment Options
- Medications: Such as ACE inhibitors, beta-blockers, and diuretics to manage symptoms and improve heart function.
- Lifestyle changes: Including a heart-healthy diet, exercise, and weight management.
- Surgery: Such as coronary bypass surgery or heart valve repair for severe cases.
- Implantable devices: Pacemakers or defibrillators to help manage heart rhythms.
Prognosis
The prognosis for heart failure varies based on its severity and the patient’s overall health. While it is a chronic condition, proper management can improve quality of life and longevity.
References & Research
Historical Background
Heart failure as a clinical syndrome was first described by ancient physicians including Hippocrates, but the modern understanding began with Richard Lower’s work on cardiac physiology in the 17th century. The New York Heart Association (NYHA) functional classification, introduced in 1928, remains the standard framework for grading heart failure severity today.
Key Research Papers
- The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure (CONSENSUS). N Engl J Med. 1987;316(23):1429-1435.
- The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure (SOLVD). N Engl J Med. 1991;325(5):293-302.
- Packer M, Coats AJ, Fowler MB, et al. Effect of carvedilol on survival in severe chronic heart failure (COPERNICUS). N Engl J Med. 2001;344(22):1651-1658.
- CIBIS-II Investigators. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet. 1999;353(9146):9-13.
- Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure (RALES). N Engl J Med. 1999;341(10):709-717.
- McMurray JJV, Packer M, Desai AS, et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure (PARADIGM-HF). N Engl J Med. 2014;371(11):993-1004.
- McMurray JJV, Solomon SD, Inzucchi SE, et al. Dapagliflozin in patients with heart failure and reduced ejection fraction (DAPA-HF). N Engl J Med. 2019;381(21):1995-2008.
- Anker SD, Butler J, Filippatos G, et al. Empagliflozin in heart failure with a preserved ejection fraction (EMPEROR-Preserved). N Engl J Med. 2021;385(16):1451-1461.
- Solomon SD, McMurray JJV, Claggett B, et al. Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction (DELIVER). N Engl J Med. 2022;387(12):1089-1098.
- Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure (SCD-HeFT). N Engl J Med. 2005;352(3):225-237.
- Cleland JGF, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure (CARE-HF). N Engl J Med. 2005;352(15):1539-1549.
- Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. J Am Coll Cardiol. 2022;79(17):e263-e421.
- McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599-3726.
Featured Videos
Congestive Heart Failure (CHF) Pathophysiology, Nursing, Treatment, Symptoms | Heart Failure Part 1
Top 7 Heart Failure Treatments Proven to Improve Outcomes
Heart Failure - Medical-Surgical (Med-Surg) - Cardiovascular System - @LevelUpRN
Heart failure diagnosis | Circulatory System and Disease | NCLEX-RN | Khan Academy
How to Manage Congestive Heart Failure
An Osmosis Video: Congestive Heart Failure (CHF) Explained
Empower Your Heart: Beating Congestive Heart Failure
Heart Failure in Dogs: 3 NEW Holistic Treatments
Congestive Heart Failure Signs & Symptoms (& Why They Occur)